Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Derom

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Acta Neurologica Belgica|April 27, 2020
Adult-onset congenital central hypoventilation syndrome due to PHOX2B mutationAntoon Meylemans, Pieter Depuydt, Elfride De Baere, et al.
Chronic Respiratory Disease|July 8, 2025
Functional status in COPD: Comparison with healthy controls and impact of an exacerbationFien Hermans, Eva Arents, Astrid Blondeel, et al.
Physiotherapy|January 31, 2024
Development and feasibility of an exercise training program in primary care for patients with COPD experiencing an acute exacerbationMarieke Wuyts, Fien Hermans, Sofie Breuls, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 20, 2016
The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study)Kai-Michael Beeh, Eric Derom, José Echave-Sustaeta, et al.
Respiration; International Review of Thoracic Diseases|May 16, 2012
Spirometric reference values for an East-African populationSanctus Musafiri, Jan P van Meerbeeck, Laurent Musango, et al.
COPD|October 13, 2015
Effects of Whole Body Vibration in Patients With COPDBihiyga Salhi, Thomas J Malfait, Georges Van Maele, et al.
ERJ Open Research|June 23, 2022
Evaluation of the Global Lung Function Initiative reference equations in Belgian adultsKevin De Soomer, Evelyn Pauwels, Hilde Vaerenberg, et al.
Acta Neurologica Belgica|October 14, 2020
Myotonic dystrophy type 1 as a major risk factor for severe COVID-19?Sebastiaan Dhont, Rutger Callens, Dieter Stevens, et al.
Clinical Pharmacokinetics|March 15, 2017
Scientific Rationale for Determining the Bioequivalence of Inhaled DrugsOmar S Usmani, Mathieu Molimard, Vaibhav Gaur, et al.
Plos One|September 20, 2018
Development of a complex intervention for early integration of palliative home care into standard care for end-stage COPD patients: A Phase 0-I studyCharlotte Scheerens, Kenneth Chambaere, Koen Pardon, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Acta Neurologica Belgica|April 27, 2020
Adult-onset congenital central hypoventilation syndrome due to PHOX2B mutationAntoon Meylemans, Pieter Depuydt, Elfride De Baere, et al.
Chronic Respiratory Disease|July 8, 2025
Functional status in COPD: Comparison with healthy controls and impact of an exacerbationFien Hermans, Eva Arents, Astrid Blondeel, et al.
Physiotherapy|January 31, 2024
Development and feasibility of an exercise training program in primary care for patients with COPD experiencing an acute exacerbationMarieke Wuyts, Fien Hermans, Sofie Breuls, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 20, 2016
The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study)Kai-Michael Beeh, Eric Derom, José Echave-Sustaeta, et al.
Respiration; International Review of Thoracic Diseases|May 16, 2012
Spirometric reference values for an East-African populationSanctus Musafiri, Jan P van Meerbeeck, Laurent Musango, et al.
COPD|October 13, 2015
Effects of Whole Body Vibration in Patients With COPDBihiyga Salhi, Thomas J Malfait, Georges Van Maele, et al.
ERJ Open Research|June 23, 2022
Evaluation of the Global Lung Function Initiative reference equations in Belgian adultsKevin De Soomer, Evelyn Pauwels, Hilde Vaerenberg, et al.
Acta Neurologica Belgica|October 14, 2020
Myotonic dystrophy type 1 as a major risk factor for severe COVID-19?Sebastiaan Dhont, Rutger Callens, Dieter Stevens, et al.
Clinical Pharmacokinetics|March 15, 2017
Scientific Rationale for Determining the Bioequivalence of Inhaled DrugsOmar S Usmani, Mathieu Molimard, Vaibhav Gaur, et al.
Plos One|September 20, 2018
Development of a complex intervention for early integration of palliative home care into standard care for end-stage COPD patients: A Phase 0-I studyCharlotte Scheerens, Kenneth Chambaere, Koen Pardon, et al.
Pageof 8